摘要
目的:观察并总结华蟾素对晚期恶性肿瘤患者免疫功能的影响。方法:选取患有晚期恶性肿瘤患者200例,A组100例采用华蟾素注射液治疗,B组100例常规对症治疗作为对照。治疗后观察A、B组患者淋巴细胞(T细胞、NK细胞、B细胞)计数、生活质量、全身感染情况等。结果:与对照组相比,A组患者NK细胞活性以及T淋巴细胞亚群显著提高,感染机会明显减少,生存质量提高,P<0.05。结论:华蟾素对晚期肿瘤患者的细胞免疫功能具有一定增强作用,可提高免疫细胞数量,提高患者生存质量。
Objective: To observe and summarize effects of TCM medicine cinobufacini on immune function in patients with advanced malignancies. Methods: 200 patients were randomly divied into two groups, group A of 100 cases were given cinobufacini injection therapy, group B of 100 cases was given conventional symptomatic treatment. After the treatment,observing the lymphocytes (Tcells, NK cells, B cells) count, quality of life, systemic infection of group A and B, etc. Results: Compared with the group B, the NK cell activity and T lymphocyte subsets in group A increased significantly. The chances of infection significantly reduced, the quality of life improved (P〈0.05). Conclusion: Cinobufacini was confirmed with enhancement on cellular immune function, can increase the number of immune cells and the quality of life.
出处
《中医临床研究》
2014年第29期19-20,共2页
Clinical Journal Of Chinese Medicine